Dyax Corp. (DYAX) Announces Appointment Of Todd Bazemore As Chief Commercial Officer
4/16/2014 6:52:00 AM
Dyax Corp. (NASDAQ: DYAX) announced today the appointment of Todd Bazemore as Executive Vice President and Chief Commercial Officer. Mr. Bazemore will be responsible for leading Dyax’s commercial organization which currently markets KALBITOR® (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
Help employers find you! Check out all the jobs and post your resume.
comments powered by